Luteinizing Hormone Releasing Hormone Analog Agonists in the Treatment of Advanced Prostatic Cancer

This publication has 13 references indexed in Scilit:

• Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.
  Proceedings of the National Academy of Sciences, 1982
• Cardiovascular Complications in the Treatment of Prostatic Carcinoma
  British Journal of Urology, 1981
• Reversible Inhibition of Testicular Steroidogenesis and Spermatogenesis by a Potent Gonadotropin-Releasing Hormone Agonist in Normal Men
  New England Journal of Medicine, 1981
• Hypothalamic-pituitary-testicular function in rats after supraphysiological doses of a highly active LRH analogue (buserelin)
  Acta Endocrinologica, 1980
• Chronic Effects of [D-Trp⁶,Pro⁹-NEt]Luteinizing Hormone-Releasing Factor on Reproductive Processes in the Male Rat*
  Endocrinology, 1979
• An Experimental Approach to the Optimum Oestrogen Dosage in Prostatic Carcinoma
  British Journal of Urology, 1978
• Chemotherapy of advanced prostatic cancer Evaluation of response parameters
  Urology, 1976
• The veterans administration cooperative urological research group's studies of cancer of the prostate
  Cancer, 1973
• Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence
  Biochemical and Biophysical Research Communications, 1971
• Prevention of Gynecomastia by Local Roentgen Irradiation in Estrogen-Treated Prostatic Carcinoma
  Scandinavian Journal of Urology and Nephrology, 1969